| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6110017 | Journal of Hepatology | 2008 | 7 Pages |
Abstract
Combination therapy with PEG-IFN-a2b and ribavirin is highly effective in inducing a virological response concerning HCV in patients with HBV/HCV co-infection. However, HBV replication may increase after the clearance of HCV and thus close monitoring for both the viruses is recommended even in patients with initially undetectable HBV-DNA.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Andrej Potthoff, Heiner Wedemeyer, Wulf O. Boecher, Thomas Berg, Stefan Zeuzem, Joachim Arnold, Ulrich Spengler, Kurt Gruengreiff, Thomas Kaeser, Marcus Schuchmann, Alexandra Bergk, Nicole Forestier, Katja Deterding, Michael P. Manns,